INCB000631

DRUG2 trials

Sponsors

Incyte Corporation

Conditions

Healthy Participants

Phase 1

Study to Assess Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, & Food Effect of Oral INCB000631 to Healthy Adult Participants

CompletedNCT06775327

Incyte CorporationHealthy Participants

Start: 2025-02-13End: 2025-05-28Updated: 2025-06-11

Study to Assess the Safety, Tolerability, and Pharmacokinetics of INCB000631 When Administered Orally to Healthy Adult Participants

TerminatedNCT07039929

Incyte CorporationHealthy Participants

Start: 2025-07-28End: 2025-10-11Updated: 2025-10-29